ScholarWorks@SUNGKYUNKWAN UNIVERSITY: LEE, SEOK YONG

Detailed Information

LEE, SEOK YONG (이석용)

Pharmacy (Pharmacy)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Pharmacokinetics:27||Genetic polymorphism:16||Genotype:12||CYP2C9:12||CYP2D6:12||s disease:11||pharmacokinetics:9||Alzheimer&apos:9||dopamine:6||Brainderived neurotrophic factor:6||HPLC:5||TRPV1:5||PBPK:5||Cognition:4||CYP2C19:4||Conditioned place preference:4||Zolpidem:4||addiction:4||selfadministration:4||Anxiety:4||Tamsulosin:4||LCMS/MS:4||Lipopolysaccharide:3||Scopolamine:3||Eucommia ulmoides Oliv. Bark:3||immunohistochemistry:3||Allele:3||Human plasma:3||Selfadministration:3||Pharmacodynamics:3||Pharmacogenomics:3||Dopamine:3||BV2 microglial cells:3||Depression:3||Polymorphisms:3||6Hydroxydopamine:3||morphine:3||NMDA receptor:3||conditioned place preference:3||Tolterodine:3||cAMP response element binding:3||Drug interaction:3||Atomoxetine:3||Neurotoxicity:3||human plasma:3||Tolperisone:3||Polymorphism:3||Behavior:2||tolperisone:2||autoradiography:2||Behavioral sensitization:2||Mepirapim:2||Benzodiazepine:2||Abuse potential:2||Methamphetamine:2||Metoprolol:2||Mice:2||5HT1A receptor:2||Cholinergic system:2||Morphine:2||Chronic mild stress:2||CH activation:2||7,8,4 &apos:2||Acetylcholinesterase:2||CPP:2||Addiction:2||SCH23390:2||drug interaction:2||NBOMe:2||SLCO1B1:2||Sibutramine:2||genetic polymorphism:2||Sleep:2||6,7,4′Trihydroxyisoflavone:2||Korean:2||locomotor activity:2||losartan:2||Ezetimibe:2||Nuclear factorkappa B:2||meloxicam:2||methamphetamine:2||Nucleus accumbens:2||nNOS:2||ABCB1:2||Learning and memory:2||Oxidative stress:2||Flurbiprofen:2||Cosmetic:2||Liquiritigenin:2||Apoptosis:2||Parkinson&apos:2||Parkinson’s disease:2||Autoradiography:2||plasma:2||raclopride:2||Celecoxib:2||4hydroxyatomoxetine:2||Physiologically based pharmacokinetic (PBPK) model:2||Glipizide:2||Evodiamine:1||Extracellular signalregulated kinase:1||FAAS:1||Flavokawain B and C:1||Flavonoids:1||Frontal cortex:1||GABA(A:1||GABA(A) receptor:1||Gastric damage:1||Genotypes:1||Ginseng berry:1||Ginsenoside Re:1||Gliclazide:1||Glucuronidation:1||Heme oxygenase1:1||Heme oxygenase1 (HO1):1||Highfat diet:1||Hydrogen peroxide:1||Hydroxymethyltolterodine:1||ICU pharmacist:1||Ileum:1||Indolines:1||Inflammation:1||Inflammatory responses:1||Intercellular adhesion molecule1:1||Interleukin1β:1||Intravenous selfadministration:1||Iron:1||Isoorientin:1||J11Cl:1||Japanese:1||K1:1||K10:1||Keratinocyte stem cells:1||Ketoesters:1||Korean Red ginseng:1||Korean red ginseng:1||LCESIMS/MS:1||Lead:1||Learning:1||Leguminosae:1||Lespedeza bicolor:1||Li:1||Loganin:1||Longitudinal smooth muscle:1||Lonicera japonica THUNB:1||Losartan:1||MDL72222:1||MDR1:1||MXP:1||Major depressive disorder:1||Malondialdehyde:1||Mechanisms of action:1||Melanogenesis:1||Melatonin:1||Meloxicam:1||Memory:1||Metabolism:1||Metal:1||Metoclopramide:1||Mitogenactivated protein kinase:1||Modafinil:1||Morphine addiction:1||Mucus secretion:1||Myeloperoxidase:1||N:1||Ndealkyltolterodine:1||Ndesmethylatomoxetine:1||Ndidesmethyl sibutramine:1||NmethylDaspartate receptor:1||NmethylDaspartic acid receptor:1||Nmonodesmethyl sibutramine:1||NMDA receptor antagonist:1||Naproxen:1||Neurochemical change:1||Neuroinflammation:1||Neuronal cell death:1||New psychoactive substance:1||Nickel:1||Nuclear factor erythroid 2related factor 2:1||Nuclear factor kappa B:1||Nuclear factorkappa B p65:1||ODesmethylvenlafaxine:1||OATP1B1:1||OCT2:1||Overactive bladder:1||P2Y12 receptor antagonist:1||PB22:1||PBPK model:1||PC12 cell:1||PKB/Akt:1||Pain control:1||Paroxetine:1||Patch:1||Pentobarbital:1||Pharmacokinet:1||Pharmacokineti:1||Pharmacokinetic:1||Phospholipase C:1||Piper methysticum:1||Piroxicam:1||Pitavastatin:1||Postsynaptic density95:1||Precision medicine:1||Prediction:1||Preservative:1||Preservative free:1||Proinflammatory responses:1||Quercetin3OβDglucuronopyranoside:1||Quinpirole:1||RTPCR:1||RTX:1||Reactive oxygen species:1||Receptor binding autoradiography:1||Relaxation:1||Restraint stress:1||Reward:1||Rg1:1||Rh1:1||Rhabdomyolysis:1||Ruthenium:1||S:1||Samlodipine:1||SB366791:1||SIRT:1||Salivary secretion:1||Sedation protocol:1||Simvastatin:1||Smooth muscle:1||Social avoidance:1||Stress:1||Sulfuretin:1||Synthetic cannabinoid:1||Synthetic cannabinoids:1||TGFβ1:1||Therapeutic effect:1||Therapeutic effects:1||Time course:1||Tolerance:1||Transdermal:1||Transient receptor potential vanilloid 1:1||Transitamplifying cells:1||Tumor necrosis factorα:1||UGT1A1:1||UPLC/MS:1||UV detection:1||Vaccinium bracteatum Thunb:1||Validation:1||Venlafaxine:1||WORDS PCBs:1||Withdrawal:1||Zafirlukast:1||Zinc:1||adverse events:1||aging:1||allele:1||amiloride:1||amlodipine:1||amyloid beta:1||amyloid beta(2535):1||angioedema:1||angiotensinconverting enzyme inhibitor:1||anxiolytic behaviors:1||anxiolyticlike effect:1||apomorphine:1||apoptosis:1||atomoxetine:1||autophagy:1||benzodiazepine:1||benzodiazepine receptor:1||bioequivalence:1||bradykinin receptor antagonist:1||brain:1||brainderived neurotrophic factor:1||buphedrone:1||butorphanol:1||cAMP element binding protein:1||calmodulinmediate:1||capsazepine:1||ceftibuten:1||clopidogrel:1||cocaine:1||cocaine reinstatement:1||cognitive deficit:1||depression:1||dicyclomine:1||dispersive liquidliquid microextraction:1||dissociative drug:1||dopamine receptor:1||dopamine release:1||dopamine transporters:1||dopaminergic transmission:1||drug seeking behavior:1||efficacy:1||elevated plus maze:1||endocrine disrupter:1||experimental design:1||g protein beta(4) subunit:1||gammaaminobutyric acid:1||gammaaminobutyric acid receptor:1||genotype:1||heme oxygenase1:1||hepatic fibrosis:1||high performance liquid chromatography:1||hotplate test:1||icatibant:1||interindividual variation:1||knockout mice:1||lamivudine:1||learning and memory:1||lower dose:1||mRNA:1||metaanalysis:1||methoxphenidine:1||mice:1||microdialysis:1||muopioid receptors:1||neurotoxicity:1||nuclear factor erythroid 2related factor 2:1||nucleus accumbens:1||olmesartan:1||ovarian cancer:1||pCREB:1||p38 MAPK:1||pentedrone:1||pharm:1||pharmaco:1||pharmacodynamics:1||pharmacoge:1||pharmacogenomics:1||pharmacok:1||pharmacoki:1||physical dependence:1||pitavastatin:1||polymorphism:1||safety:1||schizophrenia:1||simvastatin:1||sirtuin 1:1||sulfuretin:1||synthetic cannabinoid:1||tail suspension:1||tamsulosin:1||thioacetamide:1||ticagrelor:1||transient receptor potential vanilloid type 1:1||ursodeoxycholic acid:1||withdrawal:1||withdrawal symptoms:1||zaltoprofen:1||Trihydroxyisoflavone:1||αsmooth muscle actin:1||Trihydrozyisoflavone:1||1Methyl4phenyl1,2,3,6tetrahydropyridinium (MPP+):1||15deoxyDelta(12,14)prostaglandin J(2):1||2Arylbenzothiazole:1||25CNBF:1||25DNBOMe:1||25NNBOMe:1||2CC:1||2CP:1||3’:1||4’Trihydroxyisoflavone:1||5HT:1||5HT receptor:1||5HT1A:1||5HT3:1||5hydroxymethyl tolterodine:1||7:1||7,3 ',4 'Trihydroxyisoflavone:1||7NI:1||8Chlorotheophylline:1||AM1248:1||Accumbens:1||Acetylcholinerase:1||Adinazolam:1||Adverse effect:1||Albizzia julibrissin:1||Allylation:1||Allylic phosphonate:1||Alzheimer s disease:1||Alzheimer's disease:1||Amyloid beta2535:1||Analgosedation:1||Antiinflammatory activity:1||Anxiolytic behavior:1||Anxiolytic effects:1||Anxiolyticlike effec:1||BV2 microglial cells:1||Bisphenol A:1||Bladder:1||CAMP response element binding:1||CB13:1||CD71:1||CYP2B6:1||CYP2C9*3:1||CYP2D6*10:1||CYP3A4:1||Ca2(+):1||Cadmium:1||Caffeine:1||Candesartan:1||Catalytic:1||Cathinone:1||Celecoxib carboxylic acid:1||Chalcones:1||Chinese:1||Chitosan:1||Chlorogenic acid:1||Cholinergic function:1||Chronic social defeat stress:1||Chrysanthemum indicum Linne:1||Cinnamomum cassia:1||Clarithromycin:1||Clearance:1||Clomiphene:1||Cocaine:1||Cognitive deficit:1||Cognitive function:1||Combination therapy:1||Conditioned place preference (CPP):1||Contractility:1||Contraction:1||Copper:1||Coptis japonica:1||Cytotoxicity:1||D1like dopamine receptors:1||DA:1||Dendropanax morbifera:1||Diabetes:1||Diabetic nephropathy:1||Diltiazem:1||Dimenhydrinate:1||Diphenhydramine:1||Diplotype:1||Dopamine 2 receptor:1||Dopamine transporter:1||Dopaminergic pathway:1||Dose optimization:1||Dose response relation:1||Drug abuse:1||E3174:1||ERK1/2:1||EX527:1||East Asians:1||Emotional disorders:1||Ethnic difference:1||Ethyl glyoxalate:1||Eucommia ulmoides Oliv. Bark.:1||Evodia rutaecarpa:1||

STATISTICS: Total View :5,218,205; Today View :0

RSS_1.0 RSS_2.0 ATOM_1.0

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREAsamsunglib@skku.edu

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE